Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
biomarkers
exosomes
glioblastoma
miR-124-3p
miR-138-5p
miR-21-5p
miR-9-5p
miRNA
small extracellular vesicles
vimentin
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Nov 2020
11 Nov 2020
Historique:
received:
31
05
2020
revised:
01
11
2020
accepted:
06
11
2020
entrez:
14
11
2020
pubmed:
15
11
2020
medline:
3
3
2021
Statut:
epublish
Résumé
Glioblastoma (GBM), the most common primary brain tumor, is a complex and extremely aggressive disease. Despite recent advances in molecular biology, there is a lack of biomarkers, which would improve GBM's diagnosis, prognosis, and therapy. Here, we analyzed by qPCR the expression levels of a set of miRNAs in GBM and lower-grade glioma human tissue samples and performed a survival analysis
Identifiants
pubmed: 33187334
pii: ijms21228491
doi: 10.3390/ijms21228491
pmc: PMC7698225
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
MicroRNAs
0
RNA, Messenger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : Research Programme Grant P1-0390
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : Research Programme Grant P3-0108
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : postdoctoral project Z3-1869
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : Young Researcher Grant to Alja Zottel
Organisme : Interreg
ID : Interreg 2014-2020 V-A It.-Slo., Ref. No. 146
Références
EMBO J. 2011 Aug 19;30(20):4309-22
pubmed: 21857646
Neural Regen Res. 2018 Jul;13(7):1253-1262
pubmed: 30028335
Int J Mol Sci. 2018 May 04;19(5):
pubmed: 29734672
Nature. 2018 Jan 4;553(7686):96-100
pubmed: 29258294
Ther Adv Med Oncol. 2020 Apr 28;12:1758835920915302
pubmed: 32426045
Cell Mol Neurobiol. 2014 Jul;34(5):679-92
pubmed: 24691539
Am J Cancer Res. 2015 Mar 15;5(4):1531-41
pubmed: 26101716
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818802318
pubmed: 30259794
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W169-73
pubmed: 23680784
Appl Immunohistochem Mol Morphol. 2018 May/Jun;26(5):337-344
pubmed: 27556820
ESMO Open. 2017 Feb 22;1(6):e000144
pubmed: 28912963
Semin Pediatr Neurol. 2015 Mar;22(1):40-8
pubmed: 25976260
Eur J Cancer. 2012 Jul;48(10):1532-42
pubmed: 22227039
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Oncotarget. 2016 Jun 21;7(25):38892-38907
pubmed: 26646588
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Oncotarget. 2016 Jan 26;7(4):4746-59
pubmed: 26683098
Curr Opin Chem Biol. 2019 Aug;51:11-17
pubmed: 30825741
PLoS One. 2013 Oct 21;8(10):e78115
pubmed: 24205116
Mol Ther Nucleic Acids. 2013 Oct 01;2:e126
pubmed: 24084846
Sci Rep. 2019 Oct 10;9(1):14569
pubmed: 31602000
Epigenetics Chromatin. 2014 Jul 21;7:15
pubmed: 25071868
Cancer Gene Ther. 2016 Dec;23(12):415-418
pubmed: 27834360
Nat Rev Dis Primers. 2015 Jul 16;1:15017
pubmed: 27188790
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W77-83
pubmed: 23703215
Cancers (Basel). 2019 Jul 27;11(8):
pubmed: 31357584
BMC Bioinformatics. 2015 May 22;16:169
pubmed: 25994840
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205
pubmed: 31114916
Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137
pubmed: 28472511
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
PLoS One. 2012;7(4):e36248
pubmed: 22558405
Drug Resist Updat. 2019 Jan;42:35-45
pubmed: 30877905
Am J Pathol. 2012 May;180(5):1816-23
pubmed: 22538188
Med Oncol. 2018 Aug 4;35(9):122
pubmed: 30078108
Nat Neurosci. 2009 Apr;12(4):399-408
pubmed: 19287386
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W741-8
pubmed: 15980575
Cells. 2020 May 13;9(5):
pubmed: 32414170
J Clin Invest. 2014 Jul;124(7):2861-76
pubmed: 24865424
Oncotarget. 2016 Aug 30;7(35):56456-56470
pubmed: 27486821
J Clin Oncol. 2017 Jul 20;35(21):2402-2409
pubmed: 28640706
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Oncol Rep. 2018 May;39(5):2333-2341
pubmed: 29565460
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Am J Cancer Res. 2019 Jun 01;9(6):1118-1126
pubmed: 31285946
Tumour Biol. 2017 Apr;39(4):1010428317697575
pubmed: 28378633
Front Oncol. 2019 Sep 26;9:963
pubmed: 31616641
J Oncol. 2010;2010:430142
pubmed: 20652056
Pathol Res Pract. 2018 Sep;214(9):1376-1380
pubmed: 30078472
Leukemia. 2018 Mar;32(3):663-674
pubmed: 28690315
Nucleic Acids Res. 2020 Jan 8;48(D1):D127-D131
pubmed: 31504780
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
J Neurosurg. 2018 Apr;128(4):1091-1101
pubmed: 28574310
Int J Pharm. 2017 Oct 5;531(1):372-388
pubmed: 28755993
Bioinformatics. 2012 Mar 15;28(6):771-6
pubmed: 22285563
Oncotarget. 2016 Apr 26;7(17):23170-81
pubmed: 27036038
Biochem J. 2011 Nov 15;440(1):23-31
pubmed: 21770894
Sci Rep. 2016 Mar 15;6:23216
pubmed: 26976794
PLoS One. 2013 Oct 14;8(10):e77098
pubmed: 24155920
Oncotarget. 2017 Jul 4;8(27):44141-44158
pubmed: 28498803
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
J Extracell Vesicles. 2015 Aug 28;4:27495
pubmed: 26320940
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Cancer Treat Rev. 2019 Nov;80:101896
pubmed: 31541850
Cell Death Differ. 2010 Feb;17(2):221-8
pubmed: 19521422
Cancers (Basel). 2018 Apr 04;10(4):
pubmed: 29617282
Oncogene. 2018 Mar;37(12):1561-1575
pubmed: 29321659
Cancer Res. 2008 Mar 15;68(6):1945-52
pubmed: 18339876
Biochim Biophys Acta. 2013 Oct;1832(10):1697-707
pubmed: 23707559
Mol Aspects Med. 2018 Apr;60:38-51
pubmed: 29222067
Biochim Biophys Acta. 2014 Dec;1846(2):599-616
pubmed: 25286320
Genome Biol. 2019 Jan 22;20(1):18
pubmed: 30670076
Elife. 2015 Aug 12;4:
pubmed: 26267216